Epigenetic mechanisms of colon cancer prevention: What can nutrition do?

Molecular Mechanisms and Physiology of Disease: Implications for Epigenetics and Health

Volumn , Issue , 2014, Pages 401-426

  Pan, Yuan Xiang ^a   Zhang, Yukun ^a   Chen, Hong ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bioactive; Chromatin; Diet; Histone modifications; Inflammation; miRNA; Signal pathway; Transcription factor

Indexed keywords

EID: 84929887280     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-0706-9_15     Document Type: Chapter

References (173)

1. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, Garcia JM, Munoz A, Esteller M, Gonzalez-Sancho JM (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25:4116-4121
2. Aleksandrova K, Nimptsch K, Pischon T (2013) Obesity and colorectal cancer. Front Biosci (Elite Ed) 5:61-77
3. Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM (1995) Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev 14:59-73
4. Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C (2011) In melanoma, betacatenin is a suppressor of invasion. Oncogene 30:4531-4543
5. Bani S, Kaul A, Khan B, Ahmad SF, Suri KA, Gupta BD, Satti NK, Qazi GN (2006) Suppression of T lymphocyte activity by lupeol isolated from Crataeva religiosa. Phytother Res 20:279-287
6. Bardou M, Barkun AN, Martel M (2013) Obesity and colorectal cancer. Gut 62:933-947
7. Bellam N, Pasche B (2010) Tgf-beta signaling alterations and colon cancer. Cancer Treat Res 155:85-103
8. Berlau J, Glei M, Pool-Zobel BL (2004) Colon cancer risk factors from nutrition. Anal Bioanal Chem 378:737-743
9. Berner C, Aumuller E, Gnauck A, Nestelberger M, Just A, Haslberger AG (2010) Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57:183-189
10. Berrigan D, Lavigne JA, Perkins SN, Nagy TR, Barrett JC, Hursting SD (2005) Phenotypic effects of calorie restriction and insulin-like growth factor-1 treatment on body composition and bone mineral density of C57BL/6 mice: implications for cancer prevention. In Vivo 19:667-674
11. Biasi F, Tessitore L, Zanetti D, Cutrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G (2002) Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut 50:361-367
12. Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J (2008) Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 121:737-746
13. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591
14. Campisi J, Di Dda FF (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740
15. Castaneda C, Gordon PL, Fielding RA, Evans WJ, Crim MC (2000) Marginal protein intake results in reduced plasma IGF-I levels and skeletal muscle fi ber atrophy in elderly women. J Nutr Health Aging 4:85-90
16. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138:2029-2043.e10
17. Chang CH, Chyau CC, Hsieh CL, Wu YY, Ker YB, Tsen HY, Peng RY (2008) Relevance of phenolic diterpene constituents to antioxidant activity of supercritical CO(2) extract from the leaves of rosemary. Nat Prod Res 22:76-90
18. Chekulaeva M, Filipowicz W (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21:452-460
19. Chen J, Xu X (2010) Diet, epigenetic, and cancer prevention. Adv Genet 71:237-255
20. Chujo Y, Fujii N, Okita N, Konishi T, Narita T, Yamada A, Haruyama Y, Tashiro K, Chiba T, Shimokawa I, Higami Y (2013) Caloric restriction-associated remodeling of rat white adipose tissue: effects on the growth hormone/insulin-like growth factor-1 axis, sterol regulatory element binding protein-1, and macrophage infi ltration. Age (Dordr) 35:1143-1156
21. Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, Jeon YC, Sohn JH (2006) Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 38:668-672
22. Clemmons DR, Busby WH, Arai T, Nam TJ, Clarke JB, Jones JI, Ankrapp DK (1995) Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res 6:357-366
23. Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, Beug H, Ohlschlager P, Schutz A, Halbhuber KJ, Friedrich K (2005) Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7:545-555
24. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE (2006) The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692
25. Dahm CC, Keogh RH, Lentjes MA, Spencer EA, Key TJ, Greenwood DC, Cade JE, Burley VJ, Shipley MJ, Brunner EJ, Stephen AM, Mishra G, Kuh D, Fentiman IS, White IR, Luben R, Khaw KT, Rodwell Bingham SA (2010) Intake of dietary fats and colorectal cancer risk: prospective fi ndings from the UK Dietary Cohort Consortium. Cancer Epidemiol 34:562-567
26. Deka J, Wiedemann N, Anderle P, Murphy-Seiler F, Bultinck J, Eyckerman S, Stehle JC, Andre S, Vilain N, Zilian O, Robine S, Delorenzi M, Basler K, Aguet M (2010) Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. Cancer Res 70:6619-6628
27. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262
28. Elias SG, Peeters PH, Grobbee DE, Van Noord PA (2005) The 1944-1945 Dutch famine and subsequent overall cancer incidence. Cancer Epidemiol Biomarkers Prev 14:1981-1985
29. Epstein J, Sanderson IR, Macdonald TT (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103:1545-1557
30. Esteller M (2007) Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 96(suppl):R26-R30
31. Fang M, Chen D, Yang CS (2007) Dietary polyphenols may affect DNA methylation. J Nutr 137:223S-228S
32. Feng Y, Wang X, Xu L, Pan H, Zhu S, Liang Q, Huang B, Lu J (2009) The transcription factor ZBP-89 suppresses p16 expression through a histone modifi cation mechanism to affect cell senescence. FEBS J 276:4197-4206
33. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
34. Fernandez MA, De Las Heras B, Garcia MD, Saenz MT, Villar A (2001) New insights into the mechanism of action of the anti-infl ammatory triterpene lupeol. J Pharm Pharmacol 53:1533-1539
35. Fevr T, Robine S, Louvard D, Huelsken J (2007) Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 27:7551-7559
36. Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D, Pages F, Tartour E, Sautes-Fridman C (2011) Immune infi ltration in human cancer: prognostic signifi cance and disease control. Curr Top Microbiol Immunol 344:1-24
37. Galasso M, Sandhu SK, Volinia S (2012) MicroRNA expression signatures in solid malignancies. Cancer J 18:238-243
38. Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, De Garcia HA, Bonilla F, Munoz A (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24:1098-1103
39. Graves BJ, Petersen JM (1998) Specifi city within the ets family of transcription factors. Adv Cancer Res 75:1-55
40. Gregorieff A, Clevers H (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19:877-890
41. Gribovskaja-Rupp I, Kosinski L, Ludwig KA (2011) Obesity and colorectal cancer. Clin Colon Rectal Surg 24:229-243
42. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M et al (1991) Identifi cation and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
43. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006) Infl ammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126-1131
44. Gutierrez-Lugo MT, Deschamps JD, Holman TR, Suarez E, Timmermann BN (2004) Lipoxygenase inhibition by anadanthofl avone, a new fl avonoid from the aerial parts of Anadenanthera colubrina. Planta Med 70:263-265
45. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K (1994) Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fi broblasts. J Biol Chem 269:2139-2145
46. Hawinkels LJ, Paauwe M, Verspaget HW, Wiercinska E, Van Der Zon JM, Van Der Ploeg K, Koelink PJ, Lindeman JH, Mesker W, Ten Dijke P, Sier CF (2014) Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fi broblasts. Oncogene 33:97-107
47. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ (2009) Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet 18:3098-3109
48. Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, Chow WH (2006) Body mass index and colon cancer risk in Chinese people: menopause as an effect modifi er. Eur J Cancer 42:84-90
49. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, Gallagher RP, Iscovich JM, Deng-Ao J, Kaaks R, Kune GA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D, Tuyns A, Tzonou A, Watson LF, Whittemore AS, Shu Z et al (1997) The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8: 215-228
50. Hull M, Lagergren J (2013) Obesity and colorectal cancer. Gut 62:933-947
51. Hunter T, Pines J (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582
52. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54: 131-152
53. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143-159
54. Jacobsen SC, Brons C, Bork-Jensen J, Ribel-Madsen R, Yang B, Lara E, Hall E, Calvanese V, Nilsson E, Jorgensen SW, Mandrup S, Ling C, Fernandez AF, Fraga MF, Poulsen P, Vaag A (2012) Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia 55:3341-3349
55. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080
56. Jiang X, Tan J, Li J, Kivimae S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q (2008) DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifi cations. Cancer Cell 13:529-541
57. Johnson JJ, Mukhtar H (2007) Curcumin for chemoprevention of colon cancer. Cancer Lett 255:170-181
58. Johnson JJ, Syed DN, Suh Y, Heren CR, Saleem M, Siddiqui IA, Mukhtar H (2010) Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 3:1112-1123
59. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
60. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070
61. Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS (2010) Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci 67:1165-1176
62. Kansra S, Ewton DZ, Wang J, Friedman E (2000) IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells. Int J Cancer 87:373-378
63. Kelloff GJ, Schilsky RL, Alberts DS, Day RW, Guyton KZ, Pearce HL, Peck JC, Phillips R, Sigman CC (2004) Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res 10:3908-3918
64. Kim SO, Kim MR (2013) (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol 42:349-358
65. Kim SJ, Kim JS, Cho HS, Lee HJ, Kim SY, Kim S, Lee SY, Chun HS (2006) Carnosol, a component of rosemary (Rosmarinus offi cinalis L.) protects nigral dopaminergic neuronal cells. Neuroreport 17:1729-1733
66. Kim MS, Lee J, Sidransky D (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29:181-206
67. Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim HC, Chun HK, Grady WM, Kim YS (2011) Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifi es genes commonly affected by epigenetic alterations. Ann Surg Oncol 18:2338-2347
68. Klapholz-Brown Z, Walmsley GG, Nusse YM, Nusse R, Brown PO (2007) Transcriptional program induced by Wnt protein in human fi broblasts suggests mechanisms for cell cooperativity in defi ning tissue microenvironments. PLoS One 2:e945
69. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-1307
70. Kritchevsky D (2002) Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 21:147-151
71. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, Van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent infl ammatory network. Cell 133:1019-1031
72. Laake I, Thune I, Selmer R, Tretli S, Slattery ML, Veierod MB (2010) A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev 19:1511-1522
73. Lee SW, Ahn YY, Kim YS, Kang SB, Nam SW, Lee DS, Jeong HY, Kim JM (2012) The immunohistochemical expression of STAT3, Bcl-xL, and MMP-2 proteins in colon adenoma and adenocarcinoma. Gut Liver 6:45-51
74. Lelbach A, Muzes G, Feher J (2005) The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases. Acta Physiol Hung 92:97-107
75. Li Y, Liu L, Andrews LG, Tollefsbol TO (2009a) Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 125:286-296
76. Li Y, Vandenboom TG 2nd, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH (2009b) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69:6704-6712
77. Liby KT, Yore MM, Sporn MB (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7:357-369
78. Liggett WH Jr, Sidransky D (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-1206
79. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK (2002) Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 23:983-991
80. Loft S, Velthuis-Te Wierik EJ, Van Den Berg H, Poulsen HE (1995) Energy restriction and oxidative DNA damage in humans. Cancer Epidemiol Biomarkers Prev 4:515-519
81. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profi les classify human cancers. Nature 435:834-838
82. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H (2013) Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 8:e53916
83. Macinnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG (2004) Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 13:553-559
84. Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S, Itoh F (2008) Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer. World J Gastroenterol 14:2702-2714
85. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231-237
86. Marshman E, Streuli CH (2002) Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function. Breast Cancer Res 4:231-239
87. Maunakea AK, Chepelev I, Zhao K (2010) Epigenome mapping in normal and disease States. Circ Res 107:327-339
88. Mcclellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, Carson JA, Pena MM, Carnevale KA, Berger FG, Murphy EA (2012) Linking tumor-associated macrophages, infl ammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol 303: G1087-G1095
89. Milner JA (2006) Diet and cancer: facts and controversies. Nutr Cancer 56:216-224
90. Mittnacht S (1998) Control of pRB phosphorylation. Curr Opin Genet Dev 8:21-27
91. Moon RT (2005) Wnt/beta-catenin pathway. Sci STKE 2005:cm1
92. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, Kreger BE (2004) BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 28:559-567
93. Moran AE, Carothers AM, Weyant MJ, Redston M, Bertagnolli MM (2005) Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse. Cancer Res 65:1097-1104
94. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
95. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790
96. Mosieniak G, Adamowicz M, Alster O, Jaskowiak H, Szczepankiewicz AA, Wilczynski GM, Ciechomska IA, Sikora E (2012) Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mech Ageing Dev 133:444-455
97. Munoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM (2006) Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res 66:9837-9844
98. Nandakumar V, Vaid M, Katiyar SK (2011) (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32:537-544
99. Ngo SN, Williams DB, Head RJ (2011) Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr 51:946-954
100. Nguemfo EL, Dimo T, Dongmo AB, Azebaze AG, Alaoui K, Asongalem AE, Cherrah Y, Kamtchouing P (2009) Anti-oxidative and anti-infl ammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae). Infl ammopharmacology 17:37-41
101. Nian H, Delage B, Ho E, Dashwood RH (2009) Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfi des: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 50:213-221
102. Nogueira LM, Lavigne JA, Chandramouli GV, Lui H, Barrett JC, Hursting SD (2012) Dosedependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1. Cancer Med 1:275-288
103. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409:1067-1070
104. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257
105. Oshima H, Oshima M (2012) The infl ammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol 47:97-106
106. Parasramka MA, Ho E, Williams DE, Dashwood RH (2012) MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog 51:213-230
107. Park JH (2008) Inhibition of colon cancer cell growth by dietary components: role of the insulinlike growth factor (IGF) system. Asia Pac J Clin Nutr 17(suppl 1):257-260
108. Park LK, Friso S, Choi SW (2012) Nutritional infl uences on epigenetics and age-related disease. Proc Nutr Soc 71:75-83
109. Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hornig C, Steinhilber D, Schubert-Zsilavecz M, Werz O (2008) Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-infl ammatory responses of stimulated human polymorphonuclear leukocytes. Biochem Pharmacol 76:91-97
110. Prasad S, Nigam N, Kalra N, Shukla Y (2008) Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells. Mol Carcinog 47:916-924
111. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Res 50:7415-7421
112. Qasim A, O'morain C (2010) Primary prevention of colorectal cancer: are we closer to reality Eur J Gastroenterol Hepatol 22:9-17
113. Qu Z, Chow JC, Ling PR, Ziegler TR, Bistrian BR, Smith RJ (1997) Tissue-specifi c effects of chronic dietary protein restriction and gastrostomy on the insulin-like growth factor-I pathway in the liver and colon of adult rats. Metabolism 46:691-697
114. Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, Ho E, Dashwood RH (2011) Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer 10:68
115. Rao CV, Rivenson A, Simi B, Reddy BS (1995) Chemoprevention of colon cancer by dietary curcumin. Ann N Y Acad Sci 768:201-204
116. Ren M, Zhong X, Ma CY, Sun Y, Guan QB, Cui B, Guo J, Wang H, Gao L, Zhao JJ (2009) Insulinlike growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kappaB signaling pathway in FRTL thyroid cells. Acta Pharmacol Sin 30:113-119
117. Renehan AG, Flood A, Adams KF, Olden M, Hollenbeck AR, Cross AJ, Leitzmann MF (2012) Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol 176:1130-1140
118. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416:552-556
119. Robsahm TE, Aagnes B, Hjartaker A, Langseth H, Bray FI, Larsen IK (2013) Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and metaanalysis of cohort studies. Eur J Cancer Prev 22:492-505
120. Ross SA, Davis CD (2011) MicroRNA, nutrition, and cancer prevention. Adv Nutr 2:472-485
121. Rubie C, Frick VO, Pfeil S, Wagner M, Kollmar O, Kopp B, Graber S, Rau BM, Schilling MK (2007) Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 13:4996-5002
122. Saigusa S, Inoue Y, Tanaka K, Toiyama Y, Matsushita K, Kawamura M, Okugawa Y, Hiro J, Uchida K, Mohri Y, Kusunoki M (2012) Clinical signifi cance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy. Int J Oncol 41: 1643-1652
123. Saleem M, Afaq F, Adhami VM, Mukhtar H (2004) Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 23:5203-5214
124. Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H (2005) A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res 65:11203-11213
125. Saleem M, Murtaza I, Tarapore RS, Suh Y, Adhami VM, Johnson JJ, Siddiqui IA, Khan N, Asim M, Hafeez BB, Shekhani MT, Li B, Mukhtar H (2009a) Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis 30:808-817
126. Saleem M, Murtaza I, Witkowsky O, Kohl AM, Maddodi N (2009b) Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells. Biochem Biophys Res Commun 388:576-582
127. Salhia B, Baker A, Ahmann G, Auclair D, Fonseca R, Carpten J (2010) DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors. Cancer Res 70:6934-6944
128. Sancho E, Batlle E, Clevers H (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20:695-723
129. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, Mori M, Imai K, Tokino T, Shinomura Y (2007) Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28:2459-2466
130. Satoh T, Izumi M, Inukai Y, Tsutsumi Y, Nakayama N, Kosaka K, Shimojo Y, Kitajima C, Itoh K, Yokoi T, Shirasawa T (2008) Carnosic acid protects neuronal HT22 Cells through activation of the antioxidant-responsive element in free carboxylic acid-and catechol hydroxyl moietiesdependent manners. Neurosci Lett 434:260-265
131. Schetter AJ, Okayama H, Harris CC (2012) The role of microRNAs in colorectal cancer. Cancer J 18:244-252
132. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group (2009) A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fi sh. Lancet Oncol 10:1033-1044
133. Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, D'agostino RB Jr (2007) Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 16:526-531
134. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specifi c inhibition of cyclin D/CDK4. Nature 366:704-707
135. Shen G, Khor TO, Hu R, Yu S, Nair S, Ho C-T, Reddy BS, Huang M-T, Newmark HL, Kong A-NT (2007) Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res 67:9937-9944
136. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555
137. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
138. Shimizu M, Beckman BR, Hara A, Dickhoff WW (2006) Measurement of circulating salmon IGF binding protein-1: assay development, response to feeding ration and temperature, and relation to growth parameters. J Endocrinol 188:101-110
139. Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y, Moriwaki H (2010) (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem Biol Interact 185:247-252
140. Shin H, Kim JH, Lee YS, Lee YC (2012) Change in gene expression profi les of secreted frizzledrelated proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modifi cation causing inhibition of Wnt signaling. Int J Oncol 40: 1533-1542
141. Siddique HR, Mishra SK, Karnes RJ, Saleem M (2011) Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy. Clin Cancer Res 17:5379-5391
142. Smith WJ, Underwood LE, Clemmons DR (1995) Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80:443-449
143. Soliman AT, Hassan AE, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD (1986) Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20:1122-1130
144. Strathdee G, Brown R (2002) Aberrant DNA methylation in cancer: potential clinical interventions. Expert Rev Mol Med 4:1-17
145. Strillacci A, Valerii MC, Sansone P, Caggiano C, Sgromo A, Vittori L, Fiorentino M, Poggioli G, Rizzello F, Campieri M, Spisni E (2013) Loss of miR-101 expression promotes Wnt/betacatenin signalling pathway activation and malignancy in colon cancer cells. J Pathol 229:379-389
146. Subbaramaiah K, Cole PA, Dannenberg AJ (2002) Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and-independent mechanisms. Cancer Res 62:2522-2530
147. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van EM, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417-422
148. Svensson J, Lonn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjostrom L, Bengtsson BA (1998) Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab 83:362-369
149. Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O, Memar B, A'rabi A, Abbaszadegan MR (2010) p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 10:138
150. Tai J, Cheung S, Wu M, Hasman D (2012) Antiproliferation effect of Rosemary (Rosmarinus offi cinalis) on human ovarian cancer cells in vitro. Phytomedicine 19:436-443
151. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y (2005) Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24:7946-7952
152. Traka M, Gasper AV, Smith JA, Hawkey CJ, Bao Y, Mithen RF (2005) Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J Nutr 135:1865-1872
153. Tsang WP, Kwok TT (2010) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21:140-146
154. Uauy R, Solomons N (2005) Diet, nutrition, and the life-course approach to cancer prevention. J Nutr 135:2934S-2945S
155. Vanamala J, Tarver CC, Murano PS (2008) Obesity-enhanced colon cancer: functional food compounds and their mechanisms of action. Curr Cancer Drug Targets 8:611-633
156. Veganzones-De-Castro S, Rafael-Fernandez S, Vidaurreta-Lazaro M, De-La-Orden V, Mediero-Valeros B, Fernandez C, Maestro-De Las Casas ML (2012) p16 gene methylation in colorectal cancer patients with long-term follow-up. Rev Esp Enferm Dig 104:111-117
157. Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between infl ammation and cancer. Curr Pharm Des 18:3831-3852
158. Vickers MM, Bar J, Gorn-Hondermann I, Yarom N, Daneshmand M, Hanson JE, Addison CL, Asmis TR, Jonker DJ, Maroun J, Lorimer IA, Goss GD, Dimitroulakos J (2012) Stagedependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis 29:123-132
159. Wagner M, Bjerkvig R, Wiig H, Melero-Martin JM, Lin RZ, Klagsbrun M, Dudley AC (2012) Infl amed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 15:481-495
160. Wang Z, Chen H (2010) Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res 30:4537-4545
161. Wang X, Wang Q, Ives KL, Evers BM (2006) Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 12: 5346-5355
162. Wang H, Bian S, Yang CS (2011) Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32:1881-1889
163. Wang H, Li Q, Chen H (2012) Genistein affects histone modifi cations on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line. PLoS One 7:e40955
164. Wilkening S, Tavelin B, Canzian F, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P, Forsti A (2008) Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29:1202-1206
165. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ (2011) MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 32:247-253
166. Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S, Shao W, Cai J, Du Q, Zhu Y, Mao J (2013) Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Lett 329:155-163
167. Xiao Q, Hsing AW, Park Y, Moore SC, Matthews CE, De Gonzalez AB, Kitahara CM (2014) Body mass index and mortality among blacks and whites in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Obesity (Silver Spring) 22:260-268
168. Yang SY, Sales KM, Fuller BJ, Seifalian AM, Winslet MC (2008) Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide. Mol Cancer 7:17
169. Yoruker EE, Mert U, Bugra D, Yamaner S, Dalay N (2012) Promoter and histone methylation and p16(INK4A) gene expression in colon cancer. Exp Ther Med 4:865-870
170. Zhang Y, Chen H (2011a) Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med (Maywood) 236:714-722
171. Zhang Y, Chen H (2011b) Genistein, an epigenome modifi er during cancer prevention. Epigenetics 6:888-891
172. Zhang B, Halder SK, Zhang S, Datta PK (2009) Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett 277:114-120
173. Zhang Y, Li Q, Zhou D, Chen H (2013) Genistein, a soya isofl avone, prevents azoxymethaneinduced up-regulation of WNT/beta-catenin signalling and reduces colon pre-neoplasia in rats. Br J Nutr 109:33-42